Evidence map›Paper›PMID 37161611›Full record

ArticleBiomaterials research2023

Bionic natural small molecule co-assemblies towards targeted and synergistic Chemo/PDT/CDT.

Shiyao Fu, Mingao Wang, Bin Li, Xu Li, Jianjun Cheng, Haitian Zhao, Hua Zhang, Aijun Dong, Weihong Lu, Xin Yang

Open access · goldAbstract read
In one paragraph

Article in Biomaterials research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Metal-Ligand Complexes as Multifunctional Platforms for Photo-Activated Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shiyao Fu *School of Medicine and Health, Harbin Institute of Technology, No. 92, West Dazhi Street, Nangang District, Harbin, 150001, China.
Mingao Wang *Department of Nephrology, the First Affiliated Hospital of Harbin Medical University, No. 23 Youzheng Street, Nangang District, Harbin, 150001, China.
Bin Li *Academician Workstation, Jiangxi University of Traditional Chinese Medicine, 1088 Meiling Street, Wanli District, Nanchang, 330004, No, China.
Xu LiDepartment of Ophthalmology, the Second Hospital of Jilin University, Nanguan District, No. 4026 Yatai Street, Changchun, 130041, China.
Jianjun ChengSchool of Chemistry and Chemical Engineering, Harbin Institute of Technology, No.92, West Dazhi Street, Nangang District, Harbin, 150001, China.
Haitian ZhaoSchool of Medicine and Health, Harbin Institute of Technology, No. 92, West Dazhi Street, Nangang District, Harbin, 150001, China.
Hua ZhangSchool of Chemistry and Chemical Engineering, Harbin Institute of Technology, No.92, West Dazhi Street, Nangang District, Harbin, 150001, China.
Aijun DongSchool of Chemistry and Chemical Engineering, Harbin Institute of Technology, No.92, West Dazhi Street, Nangang District, Harbin, 150001, China.
Weihong LuSchool of Medicine and Health, Harbin Institute of Technology, No. 92, West Dazhi Street, Nangang District, Harbin, 150001, China.
Xin YangSchool of Medicine and Health, Harbin Institute of Technology, No. 92, West Dazhi Street, Nangang District, Harbin, 150001, China. yangxin@hit.edu.cn.
Harbin Institute of Technology · CNHarbin Medical University · CNJiangxi University of Traditional Chinese Medicine · CNSecond Affiliated Hospital of Jilin University · CN

Funding

National Natural Science Foundation of China 31972040
6 · The paper itself

Abstract

backgroundMulti-component nano-delivery systems based on chemotherapy (chemo)- photodynamic therapy (PDT)- chemodynamic therapy (CDT) have gained increased attention as a promising strategy to improve clinical outcomes in cancer treatment. However, there remains a challenge in developing biodegradable, biocompatible, less toxic, yet highly efficient multicomponent nanobased drug delivery systems (DDS). Here, our study presents the screening and development of a novel DDS based on co-assemblies natural small molecule (NSMs). These molecules (oleanolic acid, and betulinic acid) are combined with photosensitizers Chlorine6 (Ce6) and Cu

methodsA reprecipitation method was used to prepare the co-assembled nanocarrier, followed by the introduction of Cu

resultsIt was shown that CM@OABACe6/Cu NPs achieved good tumor targeting and a significant improvement in tumor accumulation. In the composite nano-assembly, the NSMs work together with the Ce6 to provide effective and safe chemo and PDT. Moreover, the effect of reduced PDT due to the depletion of reactive oxygen species (ROS) by excess glutathione (GSH) in the tumor can be counteracted when Cu

conclusionsBy constructing CM@OABACe6/Cu NPs with homologous targeting, we create a triple synergistic platform for cancer therapy using PDT, chemo, and CDT. We propose here a novel combinatorial strategy for designing more naturally co-assembled small molecules, especially for the development of multifunctional synergistic therapies that utilize NSMs.

Indexed as

4T1 cell membraneCo-assembliesSynergistic cancer treatmentTriterpenoids

Identifiers

PMID37161611
PMCPMC10169343
OpenAlexW4376121129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.